CDH1 and gastric cancer: Celecoxib, a COX-2 selective inhibitor, has been demonstrated to induce apoptosis and inhibit angiogenesis of gastric cancer and then has an inhibitory impact on E-cadherin, resulting in suppressing the invasion of advanced gastric cancer (Zhou et al., 2007).